Drugs / TOTROMBOPAG
TOTROMBOPAG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00621894 | Mar 2008 → May 2009 | autoimmune thrombocytopenic purpura | GlaxoSmithKline | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 3
| Date | Issuer | Release |
|---|---|---|
| 2008-12-08 | Ligand Pharmaceuticals | Results Ligand Presents Positive LGD-4665 Clinical Trial Results at the American Society of Hematology Annual Meeting ligand.com ↗ |
| 2008-01-08 | Ligand Pharmaceuticals | Regulatory Ligand Pharmaceuticals Awarded U.S. Patent for LGD-4665 ligand.com ↗
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) (the Company or Ligand) today announced that the United States Patent and Trademark Office issued U.S. Patent No. 7,314,887, titled "Thrombopoietin Activity Modulating Compounds and Methods," to Ligand for LGD-4665, the Company's lead thrombopoietin (TPO) receptor agonist and a family of related compounds. |
| 2007-12-08 | Ligand Pharmaceuticals | Results Ligand Presents Positive LGD-4665 Phase I Clinical Trial Results at the American Society of Hematology Annual Meeting (ASH) ligand.com ↗ |
All press releases naming this drug 5 releases
| Date | Issuer | Release |
|---|---|---|
| 2008-12-18 | Ligand Pharmaceuticals | Ligand Enters into Exclusive License Agreement with GlaxoSmithKline to License Rights to LGD-4665 and other Ligand Thrombopoietin (TPO) Molecules ligand.com ↗ |
| 2008-12-08 | Ligand Pharmaceuticals | Ligand Presents Positive LGD-4665 Clinical Trial Results at the American Society of Hematology Annual Meeting ligand.com ↗ |
| 2008-04-24 | Ligand Pharmaceuticals | Ligand Initiates Phase II Trial with LGD-4665 in Idiopathic Thrombocytopenic Purpura ligand.com ↗ |
| 2008-01-08 | Ligand Pharmaceuticals | Ligand Pharmaceuticals Awarded U.S. Patent for LGD-4665 ligand.com ↗ |
| 2007-12-08 | Ligand Pharmaceuticals | Ligand Presents Positive LGD-4665 Phase I Clinical Trial Results at the American Society of Hematology Annual Meeting (ASH) ligand.com ↗ |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TOTROMBOPAG | ChEMBL registry synonym — accepted as the source's own label CHEMBL3545303 ↗ |
| Known as | Gsk-2285921 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3545303 ↗ |
| Known as | LGD-4665 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00621894 ↗ |
| Known as | SB-559448 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3545303 ↗ |
| Modality | Small molecule | — CHEMBL3545303 ↗ |
| Route | Oral | “LGD-4665 given daily by mouth” NCT00621894 ↗ |